Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus …

J Parra-Ruiz, C Vidaillac, WE Rose… - Antimicrobial agents and …, 2010 - Am Soc Microbiol
Biofilm formation is an important virulence factor that allows bacteria to resist host responses
and antibacterial agents. The aim of the study was to assess the in vitro activities of several …

In Vitro Synergy of Colistin Combinations against Colistin-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates

C Vidaillac, L Benichou, RE Duval - Antimicrobial agents and …, 2012 - Am Soc Microbiol
Colistin resistance, although uncommon, is increasingly being reported among Gram-negative
clinical pathogens, and an understanding of its impact on the activity of antimicrobials is …

Evaluation of vancomycin susceptibility testing for methicillin-resistant Staphylococcus aureus: comparison of Etest and three automated testing methods

MJ Rybak, C Vidaillac, HS Sader… - Journal of clinical …, 2013 - Am Soc Microbiol
We evaluated the ability of four commercial MIC testing systems (MicroScan, Vitek 2,
Phoenix, and Etest) to detect vancomycin MIC values of ≤1 to ≥2 in 200 methicillin-resistant …

Synthesis of Omeprazole Analogues and Evaluation of These as Potential Inhibitors of the Multidrug Efflux Pump NorA of Staphylococcus aureus

C Vidaillac, J Guillon, C Arpin… - Antimicrobial agents …, 2007 - Am Soc Microbiol
A series of 11 pyrrolo[1,2-a]quinoxaline derivatives, 1a to 1k, sharing structural analogies
with omeprazole, a eukaryotic efflux pump inhibitor (EPI) used as an antiulcer agent, was …

Gender differences in bronchiectasis: a real issue?

C Vidaillac, VFL Yong, TK Jaggi, MM Soh… - Breathe, 2018 - Eur Respiratory Soc
Gender differences in chronic respiratory disease, including cystic fibrosis and non-cystic
fibrosis bronchiectasis are clinically apparent and of increasing importance. Differences in …

Pseudomonas aeruginosa in bronchiectasis: infection, inflammation, and therapies

C Vidaillac, SH Chotirmall - Expert review of respiratory medicine, 2021 - Taylor & Francis
Introduction: Bronchiectasis is a chronic endobronchial suppurative disease characterized
by irreversibly dilated bronchi damaged by repeated polymicrobial infections and …

Thieno [2, 3-d] pyrimidinedione derivatives as antibacterial agents

MB Dewal, AS Wani, C Vidaillac, D Oupickż… - European journal of …, 2012 - Elsevier
Several thieno[2,3-d]pyrimidinediones have been synthesized and examined for antibacterial
activity against a range of Gram-positive and Gram-negative pathogens. Two compounds …

[HTML][HTML] Evaluation of high-dose daptomycin versus vancomycin alone or combined with clarithromycin or rifampin against Staphylococcus aureus and S. epidermidis …

AD Hall Snyder, C Vidaillac, W Rose… - Infectious diseases and …, 2015 - Springer
Introduction Medical device infections are associated with significant morbidity and mortality.
These difficult-to-treat infections often result in antibiotic failure and resistance. …

Novel Daptomycin Combinations against Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial …

ME Steed, C Vidaillac, MJ Rybak - Antimicrobial agents and …, 2010 - Am Soc Microbiol
Reduced susceptibility to daptomycin has been reported in patients with infections due to
methicillin-resistant Staphylococcus aureus (MRSA). Although infections with daptomycin-…

Alternative Mutational Pathways to Intermediate Resistance to Vancomycin in Methicillin-Resistant Staphylococcus aureus

C Vidaillac, S Gardete, R Tewhey… - The Journal of …, 2013 - academic.oup.com
Background. We used 2 in vitro experimental systems to compare phenotypic and genotypic
changes that accompany selection of mutants of methicillin-resistant Staphylococcus …